A team at the Canadian Centre for Vaccinology at Dalhousie University was supposed to work with CanSino to run the first Canadian clinical trials for a possible COVID-19 vaccine. CanSino's vaccine, called Ad5-nCoV, was already being run through human trials in China and has shown promising results. In May, Health Canada gave the go-ahead for the Canadian trials to begin, and the hope was that clinical trials in Halifax could begin within weeks. (Reuters)In an emailed statement, the National Research Council (NRC) said the vaccine candidate had not been approved by Chinese customs to ship to Canada. "The process is not clear to the NRC, but CanSino does not have the authority to ship the vaccine at this time."

Source: CBC News August 26, 2020 21:56 UTC